ACAD
ACADIA Pharmaceuticals Inc
Price:  
18.55 
USD
Volume:  
1,133,372.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Relative Valuation

5.8%
Upside

As of 2025-02-09, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 19.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.55 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 5.8%.

The range of the Relative Valuation is 15.40 - 25.35 USD.

Range Selected
Trailing P/E multiples 19.9x - 25.3x 22.2x
Forward P/E multiples 24.6x - 32.8x 28.6x
Fair Price 15.40 - 25.35 19.62
Upside -17.0% - 36.6% 5.8%
18.55 USD
Stock Price
19.62 USD
Fair Price

Acadia Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 24.02
2025-02-06 24.77
2025-02-05 25.38
2025-02-04 24.25
2025-02-03 23.97
2025-01-31 24.16
2025-01-30 24.20
2025-01-29 23.79
2025-01-28 23.82
2025-01-27 23.66
2025-01-24 24.17
2025-01-23 24.70
2025-01-22 23.06
2025-01-21 23.16
2025-01-17 22.75
2025-01-16 22.68
2025-01-15 22.67
2025-01-14 21.88
2025-01-13 23.18
2025-01-10 22.35
2025-01-08 22.79
2025-01-07 22.52
2025-01-06 22.61
2025-01-03 23.84
2025-01-02 24.16
2024-12-31 23.76
2024-12-30 21.61
2024-12-27 21.95
2024-12-26 22.49
2024-12-24 22.10
2024-12-23 22.23
2024-12-20 21.84
2024-12-19 21.66
2024-12-18 21.90
2024-12-17 22.54
2024-12-16 22.45
2024-12-13 22.35
2024-12-12 22.35
2024-12-11 23.33
2024-12-10 23.99
2024-12-09 24.29
2024-12-06 22.37
2024-12-05 21.64
2024-12-04 22.23
2024-12-03 21.11
2024-12-02 21.51
2024-11-29 21.13
2024-11-27 21.09
2024-11-26 20.99
2024-11-25 21.42